Skip to content

Insider · CIK 0001506045

Mauro Ferrari

director

Files at ARWR (ARROWHEAD PHARMACEUTICALS, INC.). First filing Dec 1, 2025, latest Dec 30, 2025.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 2
$0 bought, $1.0M sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

ARWR: ARROWHEAD PHARMACEUTICALS, INC.

ARWROct 9, 2026 · close 62.75

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
28Weak
ARWRsell 710b5-1
ARROWHEAD PHARMACEUTICALS, INC.
$527k
7,530 shares
-10%+602% from low-1% from high
46Moderate
ARWRsell 2
ARROWHEAD PHARMACEUTICALS, INC.
$493k
8,750 shares
-11%+428% from low-9% from high

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Dec 26, 2025ARWR
ARROWHEAD PHARMACEUTICALS, INC.
SOpen-market sale
Common Stock10b5-1
-7,530$70.00$527k69,053Dec 30, 2025
Dec 16, 2025ARWR
ARROWHEAD PHARMACEUTICALS, INC.
AGrant or award
Common Stock
+7,819$0.00$076,583Dec 18, 2025
Nov 28, 2025ARWR
ARROWHEAD PHARMACEUTICALS, INC.
SOpen-market sale
Common Stock
-8,750$56.39$493k68,764Dec 1, 2025
Dec 18, 2024ARWR
ARROWHEAD PHARMACEUTICALS, INC.
AGrant or award
Common Stock
+16,733$22.99$385k77,514Dec 20, 2024

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Mauro Ferrari: insider trades and track record | InsiderTell